E-LIB Suche - Ergebnisse für: Alvero, Carmelita

1

P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SA..:

Kremyanskaya, Marina ; Harrison, Claire ; Bose, Prithviraj...
HemaSphere. 7 (2023) S3 - p. e0578580 , 2023

2

Efficacy, Safety, and Tolerability of Doravirine/Lamivudine..:

Rungmaitree, Supattra ; Aurpibul, Linda ; Best, Brookie M...
Journal of the Pediatric Infectious Diseases Society. 12 (2023) 12 - p. 602-609 , 2023

Link: https://doi.org/10.1093/..

3

Population Pharmacokinetic Modeling of Dolutegravir to Opti..:

Chandasana, Hardik ; Thapar, Mita ; Hayes, Siobhan...
Clinical Pharmacokinetics. 62 (2023) 10 - p. 1445-1459 , 2023

Link: https://doi.org/10.1007/..

4

Long-Term Safety and Efficacy of Dolutegravir in Treatment-..:

The P1093 Study Team ; Wiznia, Andrew ; George, Kathleen...
Journal of the Pediatric Infectious Diseases Society. 9 (2019) 2 - p. 159-165 , 2019

Link: https://doi.org/10.1093/..

5

Comparison of Prediction Models for Lynch Syndrome Among In..:

Kastrinos, Fay ; Ojha, Rohit P. ; Leenen, Celine...
JNCI: Journal of the National Cancer Institute. 108 (2015) 2 - p. , 2015

Link: https://doi.org/10.1093/..

6

Long-Term Safety and Efficacy of Dolutegravir in HIV Treatm..:

Viani, Rolando ; Alvero, Carmelita ; Fenton, Terence...
Open Forum Infectious Diseases. 2 (2015) suppl_1 - p. , 2015

Link: https://doi.org/10.1093/..

7

Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Ralt..:

Nachman, Sharon ; Zheng, Nan ; Acosta, Edward P....
Clinical Infectious Diseases. 58 (2014) 3 - p. 413-422 , 2014

Link: https://www.jstor.org/st..

8

Poster: ABCL-088 Subgroup Analysis in RE-MIND2: An Observat..:

Nowakowski, Grzegorz ; Yoon, Dok Hyun ; Joffe, Erel...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S166 , 2022

Link: https://doi.org/10.1016/..

9

ABCL-088 Subgroup Analysis in RE-MIND2: An Observational, R..:

Nowakowski, Grzegorz ; Yoon, Dok Hyun ; Joffe, Erel...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S359 , 2022

Link: https://doi.org/10.1016/..

10

Etravirine in treatment-experienced HIV-1-infected children..:

MacBrayne, Christine E. ; Rutstein, Richard M. ; Wiznia, Andrew A....
AIDS. 35 (2021) 9 - p. 1413-1421 , 2021

Link: https://doi.org/10.1097/..

11

Population Pharmacokinetic Modeling of Dolutegravir to Opti..:

Chandasana, Hardik ; Thapar, Mita ; Hayes, Siobhan...
qt3sd6d6wj. , 2023

Link: https://escholarship.org..

12

Population Pharmacokinetic Modeling of Dolutegravir to Opti..:

Chandasana, Hardik ; Thapar, Mita ; Hayes, Siobhan...
https://discovery.ucl.ac.uk/id/eprint/10175927/1/s40262-023-01289-5.pdf. , 2023

Link: https://discovery.ucl.ac..

13

Long-Term Safety and Efficacy of Dolutegravir in Treatment-..:

Viani, Rolando M ; Ruel, Theodore ; Alvero, Carmelita...
qt4ks5w91x. , 2020

Link: https://escholarship.org..

14

P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SA..:

Marina Kremyanskaya ; Claire Harrison ; Prithviraj Bose...
http://journals.lww.com/10.1097/01.HS9.0000970976.05785.80. , 2023

Link: https://doi.org/10.1097/..